Odyssey Health, Inc. (ODYY)
OTCMKTS
· Delayed Price · Currency is USD
0.0110
+0.0019 (20.88%)
Mar 12, 2025, 4:00 PM EST
Odyssey Health Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
1.03M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.18B |
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 43.26M |
| BioStem Technologies | 210.49M |
Odyssey Health News
- 1 year ago - Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity - Accesswire
- 1 year ago - Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc. - Accesswire
- 1 year ago - Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc. - Accesswire
- 1 year ago - Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion - Accesswire
- 1 year ago - Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders - Accesswire
- 1 year ago - Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc. - Accesswire
- 1 year ago - Odyssey Health Inc. Begins Trading on the OTCQB - Accesswire
- 1 year ago - Odyssey Health, Inc. Presents Concussion Treatment Data at the Military Health System Research Symposium - MHSRS - Accesswire